TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04780529 — Predictive Biomarker (PRD): GUCY2C mRNA
Genes: GUCY2C; GUC2C; STAR
Study NCT05303415 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05988918 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04303975 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05312606 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05312606 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06709872 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT06709872 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study NCT06715098 — Predictive Biomarker (PRD): SEMG1 mRNA
Genes: SEMG1; SEMG
Study NCT05346328 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04887675 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06484504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06484504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04853771 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06101368 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06101368 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06101368 — Safety Biomarker (SAF): BDNF
Study NCT05221008 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06000592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06478238 — Predictive Biomarker (PRD): CYP2U1 mRNA
Genes: CYP2U1
Study NCT05921617 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05921617 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05140434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05188430 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06498115 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04790747 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study NCT04316559 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04867083 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05362110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06375668 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06677385 — Safety Biomarker (SAF): Interleukin 1
Study NCT06677255 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04484701 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06014775 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06014775 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05384834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05017571 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06392451 — Predictive Biomarker (PRD): NES mRNA
Genes: NES; Nbla00170
Study NCT04712851 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05939752 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05993052 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06255795 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06360744 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT04896853 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04960072 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06408493 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06408493 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06408493 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05547386 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05211089 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT00100737 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06154668 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05728008 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06715020 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT06718309 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06718309 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06717828 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04969172 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT05249036 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04812431 — Predictive Biomarker (PRD): NCAM1 mRNA
Genes: NCAM1; NCAM
Study NCT05226416 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04861779 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06218303 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT06016322 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05290662 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04847440 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06107543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06405295 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05500807 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05911581 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06302803 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04755764 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05015010 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06677034 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06677034 — Safety Biomarker (SAF): BDNF
Study NCT05348096 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06076161 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05896319 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06553365 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT06426823 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05377567 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05377567 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05325229 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04603469 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04998227 — Predictive Biomarker (PRD): LTBP4 mRNA
Genes: LTBP4
Study NCT04895930 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06436144 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06436144 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06436144 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT06436144 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05372588 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05603013 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05932082 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05663463 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05076058 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT05076058 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06307301 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06032117 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05934383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00211419 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05407805 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06437860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03810898 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05985707 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05208372 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06479187 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04965298 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06154317 — Predictive Biomarker (PRD): SOX4 mRNA
Genes: SOX4
Study NCT06154317 — Predictive Biomarker (PRD): XBP1 mRNA
Genes: XBP1; TREB5; XBP2
Study NCT05249205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05266846 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05000216 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06292377 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06292377 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05043181 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study NCT05043181 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06071598 — Predictive Biomarker (PRD): MFSD2A mRNA
Genes: MFSD2A; MFSD2; NLS1; HMFN0656; PP9177; UNQ300/PRO341
Study NCT06071598 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study NCT05748301 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05955391 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04530305 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04530305 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05609825 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05207748 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05583110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05075083 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05766969 — Predictive Biomarker (PRD): DIAPH2 mRNA
Genes: DIAPH2; DIA
Study NCT05316246 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05255302 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05426317 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05426317 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT00000900 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05533515 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04927481 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06243614 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05886153 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04797377 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06252844 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06252844 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06252844 — Safety Biomarker (SAF): BDNF
Study NCT05968859 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05274412 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04746131 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04868942 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06448975 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04722003 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT04891835 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04891835 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04646902 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT06206824 — Predictive Biomarker (PRD): DYRK1A mRNA
Genes: DYRK1A; DYRK; MNB; MNBH
Study NCT05605548 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05484466 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05146375 — Predictive Biomarker (PRD): TGFBR2 mRNA
Genes: TGFBR2
Study NCT04769817 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04380155 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT04380155 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT06224907 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT05789771 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05789771 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05255692 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06549465 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05033314 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04143581 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04143581 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06335914 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06251622 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06314763 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06327386 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04847570 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002343 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04972188 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT04972188 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study NCT05758012 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06105125 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06370312 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study NCT04526834 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06124066 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06124066 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04796129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05252208 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04853602 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT04901936 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06287021 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05420090 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05420090 — Safety Biomarker (SAF): BDNF
Study NCT05133375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05654467 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05518253 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT06285149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06007508 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06185166 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT05434273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04581733 — Predictive Biomarker (PRD): TK2 mRNA
Genes: TK2
Study NCT05237453 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study NCT06238752 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06554756 — Predictive Biomarker (PRD): ANXA2 mRNA
Genes: ANXA2; ANX2; ANX2L4; CAL1H; LPC2D
Study NCT06149923 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT04844541 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05169372 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06199908 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT05302895 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05770297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05770297 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04644341 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06137105 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05685420 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT04925336 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06401499 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT05282875 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT05402813 — Predictive Biomarker (PRD): GJB2 mRNA
Genes: GJB2
Study NCT05402813 — Predictive Biomarker (PRD): OTOF mRNA
Genes: OTOF; FER1L2
Study NCT05794880 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05588115 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05394506 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT04766320 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT03633955 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT05881317 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04348617 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06416267 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT04727840 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06387069 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06387069 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06319209 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03938987 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06143371 — Predictive Biomarker (PRD): IL1RAP mRNA
Genes: IL1RAP; C3orf13; IL1R3
Study NCT06100146 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06010862 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04831190 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05247684 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06300424 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05598853 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05059093 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT06518668 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05572060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05573542 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05725135 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05640180 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05841719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05136157 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05869968 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05869968 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05711914 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05711914 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05711914 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05989542 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05746715 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study NCT05085067 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05238519 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT06469190 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04761016 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04805996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04877821 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06196177 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05106946 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04750343 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04641741 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04641741 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT04641741 — Predictive Biomarker (PRD): CRLF2 mRNA
Genes: CRLF2; CRL2; ILXR; TSLPR
Study NCT04641741 — Safety Biomarker (SAF): Hypoxanthine-guanine phosphoribosyltransferase
Genes: HPRT1; HPRT
Study NCT05115370 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06073418 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06300177 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00006330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06411743 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00607802 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06524271 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT06524271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06524271 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06305585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05932576 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05173012 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT04998500 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04701866 — Surrogate Endpoint (SUR): Blood pressure